T
Tamara Pilishvili
Researcher at Centers for Disease Control and Prevention
Publications - 89
Citations - 12992
Tamara Pilishvili is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Pneumococcal conjugate vaccine & Medicine. The author has an hindex of 30, co-authored 67 publications receiving 10996 citations. Previous affiliations of Tamara Pilishvili include National Center for Immunization and Respiratory Diseases & United States Department of Health and Human Services.
Papers
More filters
Journal ArticleDOI
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
Cynthia G. Whitney,Monica M. Farley,James L. Hadler,Lee H. Harrison,Nancy M. Bennett,Ruth Lynfield,Arthur Reingold,Paul R. Cieslak,Tamara Pilishvili,Delois Jackson,Richard R. Facklam,James H. Jorgensen,Anne Schuchat +12 more
TL;DR: The use of the pneumococcal conjugate vaccine is preventing disease in young children, for whom the vaccine is indicated, and may be reducing the rate of disease in adults.
Journal ArticleDOI
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
Stephanie R. Bialek,Ellen O. Boundy,Virginia B. Bowen,Nancy A. Chow,Amanda C. Cohn,Nicole F. Dowling,Sascha R. Ellington,Ryan Gierke,Aron J. Hall,Jessica R. MacNeil,Priti Patel,Georgina Peacock,Tamara Pilishvili,Hilda Razzaghi,Nia Reed,Matthew D. Ritchey,Erin K. Sauber-Schatz +16 more
TL;DR: COVID-19 cases in the United States that occurred during February 12-March 16, 2020 and severity of disease (hospitalization, admission to intensive care unit [ICU], and death) were analyzed by age group, suggesting that the risk for serious disease and death from CO VID-19 is higher in older age groups.
Journal ArticleDOI
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili,Catherine Lexau,Monica M. Farley,Monica M. Farley,James L. Hadler,Lee H. Harrison,Nancy M. Bennett,Arthur Reingold,Ann Thomas,William Schaffner,Allen S. Craig,Philip J. Smith,Bernard Beall,Cynthia G. Whitney,Matthew R. Moore +14 more
TL;DR: Dramatic reductions in IPD after PCV7 introduction in the United States remain evident 7 years later, and IPD rates caused by serotype 19A and other non-PCV7 types have increased but remain low relative to decreases in PCV 7-type IPD.
Journal ArticleDOI
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.
Stephanie R. Bialek,Ryan Gierke,Michelle M Hughes,Lucy A McNamara,Tamara Pilishvili,Tami H. Skoff +5 more
TL;DR: Data support previous findings that children with COVID-19 might not have reported fever or cough as often as do adults and social distancing and everyday preventive behaviors remain important for all age groups as patients with less serious illness and those without symptoms likely play an important role in disease transmission.
Journal ArticleDOI
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
Catherine Lexau,Ruth Lynfield,Richard Danila,Tamara Pilishvili,Richard R. Facklam,Monica M. Farley,Lee H. Harrison,William Schaffner,Arthur Reingold,Nancy M. Bennett,James L. Hadler,Paul R. Cieslak,Cynthia G. Whitney +12 more
TL;DR: The findings indicate that use of conjugate vaccine in children has substantially benefited older adults, and persons with certain comorbid conditions may benefit less than healthier persons from the indirect effects of the new vaccine.